Christofer Juhlin

Christofer Juhlin

Affiliated to Teaching/Tutoring | Docent
Visiting address: J6:20 BioClinicum, Akademiska stråket 1, 17164 SOLNA
Postal address: K7 Onkologi-Patologi, K7 Forskning Larsson Catharina Juhlin, 171 77 Stockholm
Part of:

About me

  • * Associate Professor of Experimental Pathology at Karolinska Institutet.
    * Deputy Senior Consultant in Surgical Pathology, Karolinska University
    Hospital, Stockholm, Sweden with special focus on endocrine pathology.
    * Bachelor of Science in Molecular Biology, Stockholm University, Stockholm,
    Sweden.
    * Project group leader for research team investigating genetical mechanisms
    underlying endocrine tumorigenesis.
    * Previously /visiting research scholar /at Yale School of Medicine, New
    Haven, CT, USA (2013-2014).
    * Awarded the M.D. Ph.D Scholarship at Karolinska Institutet, Stockholm,
    Sweden in 2005. The grant is equvalent of financing of a PhD student
    for four years.
    * Awarded the Clinical Postdoctoral Stipend in 2012 (supported by the
    Stockholm County Council (clinical postdoctorial appointment), equivalent
    of four years of half-time financing.
    * Awarded a scholarship from Erik and Edith Fernström's Foundation for
    Medical Research in 2013.
    * Currently grant-holder from the Swedish Cancer Society, the Swedish
    Medical Society, the Swedish Society of Endocrinology, KI Funds and The
    Cancer Society of Stockholm and the Swedish Society for Medical Research
    (SSMF).
    * Awarded the Junior Clinical Investigator Award from The Swedish Cancer
    Society (grant covering half-time salary for research from 2017
    to 2022).
    * Authoring three different WHO classification books in 2022.

Research

  • My project group is investigating the genetical mechanisms which propel the
    development of cancer in hormone-secreting organs such as the thyroid,
    parathyroids and adrenal glands. By utilizing modern molecular techniques to
    approach specific hypotheses, results are implemented with the focus to
    deliver improved diagnostics and prognostics regarding these tumor types.
    As an example, the project group has aided in the identification of two
    molecular markers for malignant parathyroid tumors (parafibromin and APC)
    which have been implemented for clinical use as diagnostic markers at several
    international institutions, including Karolinska University Hospital.

Articles

All other publications

Employments

  • Affiliated to Teaching/Tutoring, Department of Oncology-Pathology, Karolinska Institutet, 2023-2026

Degrees and Education

  • Docent, Karolinska Institutet, 2016
  • Degree Of Doctor Of Philosophy, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2009
  • University Medical Degree, Karolinska Institutet, 2008

News from KI

Events from KI